NCS Multistage (NASDAQ:NCSM – Get Free Report) was downgraded by stock analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a report released on Thursday.
NCS Multistage Stock Down 3.7%
NCSM stock opened at $30.81 on Thursday. The stock’s fifty day simple moving average is $31.28 and its two-hundred day simple moving average is $28.32. The company has a current ratio of 4.50, a quick ratio of 2.63 and a debt-to-equity ratio of 0.06. NCS Multistage has a 1-year low of $15.90 and a 1-year high of $38.95. The stock has a market cap of $78.29 million, a P/E ratio of 1.81 and a beta of 0.66.
NCS Multistage (NASDAQ:NCSM – Get Free Report) last posted its quarterly earnings data on Wednesday, April 30th. The company reported $1.51 earnings per share for the quarter, topping the consensus estimate of $0.79 by $0.72. NCS Multistage had a return on equity of 2.60% and a net margin of 27.99%. The business had revenue of $50.01 million for the quarter, compared to analysts’ expectations of $44.40 million.
Institutional Inflows and Outflows
NCS Multistage Company Profile
NCS Multistage Holdings, Inc provides engineered products and support services for oil and natural gas well completions and construction, and field development strategies in the United States, Canada, and internationally. It offers fracturing systems, which include casing-installed sliding sleeves, downhole frac isolation assemblies, and sand jet perforating products; enhanced recovery products, such as sliding sleeve, as well as Terrus system, an injection control device; repeat precision products comprising composite frac plugs and bridge plugs, single-use disposable setting tools, express systems, and related products; chemical and radioactive tracer diagnostics services; and well construction products, including AirLock casing buoyancy system, Vecturon and Vectraset liner hanger systems, and Toe initiation sleeves.
Recommended Stories
- Five stocks we like better than NCS Multistage
- Breakout Stocks: What They Are and How to Identify Them
- Pfizer’s 7.5% Dividend: Income Haven or House of Cards?
- Investing in the High PE Growth Stocks
- 3 Trades Members of Congress Are Making Right Now
- How to Profit From Value Investing
- TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain
Receive News & Ratings for NCS Multistage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NCS Multistage and related companies with MarketBeat.com's FREE daily email newsletter.